Navigation Links
Fat Reduction Market in Europe to Soar Despite Economic Downturn

WALTHAM, Mass., July 16 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the fat reduction device market will experience the highest growth of all body contouring devices in Europe through 2013. MRG's European Markets for Body Contouring Devices 2009 report finds that the fat reduction segment will be fueled by physician adoption of newer modalities like transdermal ultrasound and laser, light, and energy fat reduction devices, which offer patients less invasive solutions than traditional liposuction.

Transdermal ultrasound and laser-assisted liposuction (LAL) procedures will experience particularly strong growth over the next five years, with patient desire for minimally invasive procedures fueling both segments. Transdermal ultrasound procedures can be performed in an hour and without any incisions, allowing patients to return to their normal routine afterwards. Until recently, the market for transdermal ultrasound was dominated by UltraShape; however, the competitive landscape has changed with the launch of Medicis' LipoSonix in mid-2008, and it will continue to shift over the next five years as new firms enter the market in an attempt to capitalize on the rapid growth.

"The LAL market is undergoing similar competitive changes. As LAL continues to stimulate patient demand, physicians will purchase new LAL devices and new competitors will emerge in order to capitalize on the market's tremendous potential," says Kevin Flewwelling, Manager of the Aesthetics division at MRG. "DEKA's SmartLipo device was one of the first LAL devices available in the European market; however, many competitors have since launched LAL devices, including Cynosure, Eleme Medical, Sciton, Syneron, and others."

MRG's European Markets for Body Contouring Devices 2009 report covers the markets for cellulite reduction, skin tightening, fat reduction, and gastric bands in France, Germany, Italy, Spain, and the UK. The report provides full breakdowns of body contouring procedures by type as well as device unit sales by subtype, including five-year forecasts, up-to-date market shares, and in-depth qualitative insights.

About Millennium Research Group

Millennium Research Group (, a Decision Resources, Inc. company (, is the global authority on medical technology market intelligence and the leading provider of strategic information to the health care sector. The company provides specialized industry expertise through multiclient market research, ongoing Marketrack(TM) projects, customer loyalty tracking, facility-level procedure forecasting, and customized solutions.

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information, and insights on important sectors of the health care industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

    For more information, contact:

    Amy Krohn
    Millennium Research Group
    416-364-7776 x101

    Elizabeth Marshall
    Decision Resources Inc.

SOURCE Millennium Research Group
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Federal Judge Orders Schwarzenegger Administration to Comply with Order That Blocks State Reduction for IHSS Worker Wages
2. Caraco Pharmaceutical Laboratories, Ltd. Announces an Indefinite Reduction in its Workforce
3. Hospital Bedside Technology Solution Results in 74 Percent Reduction in Heart Failure Readmission Rate
4. Employees Increasingly Accept and Understand Reductions in Health Plan Benefits and Premium-Cost Sharing
5. Studies Show Groundbreaking 22% Reduction in Depression Symptoms in 4 Hours
6. Maricopa Integrated Health System Reports 90 Percent Reduction in Pressure Ulcers
7. Pharmaceutical Companies Seek to Balance Quality Assurance & Cost Reduction
8. AstraZeneca Studies Show Relief of Nighttime Heartburn and Reduction in GERD-Related Sleep Disturbances
9. New study finds Power Plate exercise aids in weight loss, reduction of harmful visceral fat
10. New Study Finds Power Plate(R) Exercise Aids in Weight Loss, Reduction of Harmful Visceral Fat
11. Massive decline in rates of coronary death in Iceland are largely attributed to risk factor reductions in the population
Post Your Comments:
(Date:10/13/2017)... (PRWEB) , ... October 13, ... ... School of Pharmacy (SOP) alumni Hannah Randall, PharmD ‘17, and Jennifer Huggins, ... professionals on guideline updates for the primary prevention of cardiovascular diseases during ...
(Date:10/13/2017)... LUIS OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... Alzheimer’s or dementia. However, many long-term care insurance companies have a waiver for care ... is the 90-day elimination period, when the family pays for care, is often waived, ...
(Date:10/13/2017)... ... October 13, 2017 , ... Global Healthcare Management’s 4th Annual ... in Milford, NJ. This free event, sponsored by Global Healthcare Management’s CEO, Jon ... fun run is geared towards children of all ages; it is a non-competitive, non-timed ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a ... has been awarded a contract by the Center for Medicare and Medicaid Services ... accelerate the enterprise use of Agile methodologies in a consistent and high value ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... services for healthcare compliance program management, will showcase a range of technology and ... for Assisted Living (NCAL) Convention and Expo to be held October 14–18, 2017 ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... Cohen Veterans Bioscience and Early Signal Foundation announce a ... sensors for real-time monitoring of patients with trauma-related and ... focused on disruptive health solutions for rare disorders and ... record and integrate behavioral, cognitive, physiological and contextual data. ... ...
(Date:9/23/2017)... -- Janssen Biotech, Inc. (Janssen) announced today that it ... Food and Drug Administration (FDA) for the Biologics License ... of moderately to severely active rheumatoid arthritis (RA). The ... to further evaluate the safety of sirukumab in the ... "We are disappointed by ...
(Date:9/18/2017)... , Sept. 18, 2017  PMD Healthcare of ... Pharmacy of Kalamazoo, Mich. , have ... service that expedites and streamlines patient and provider access ... 2.0, and wellness management services.  ... used to measure lung function for a variety of ...
Breaking Medicine Technology: